CLINICAL_TRIALS
trial_result
· 2019-02-20
Clinical Trial Update: Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy [Phase 2]
Summary
Phase 2 safety study of eteplirsen in advanced-stage Duchenne muscular dystrophy completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sarepta Therapeutics, Inc. | Conditions: Muscular Dystrophy, Duchenne | Phase 2 | Status: COMPLETED | Results posted: 2019-02-20